Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat (original) (raw)
Choi-Lundberg DL, Bohn MC . Applications of gene therapy to neurological diseases and injuries. In: Quesenberry PJ, Stein GS, Forget B, Weissman S (eds) . Stem Cell Biology and Gene Therapy Wiley-Liss: New York 1998 503–553 Google Scholar
Connor B, Dragunow M . The role of neuronal growth factors in neurodegenerative disorders of the human brain Brain Res 1998 27: 1–39 ArticleCAS Google Scholar
Lindsay RM . Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor Neurobiol Aging 1994 15: 249–251 ArticleCASPubMed Google Scholar
Bohn MC, Choi-Lundberg DL . Gene therapies for Parkinson’s disease. In: Chiocca EA, Breakfield XO (eds) . Gene Therapy for Neurological Disorders and Brain Tumors Humana Press: Totowa, NJ 1997 377–395 Google Scholar
Unsicker K . GDNF: a cytokine at the interface of TGF-betas and neurotrophins Cell Tiss Res 1996 286: 175–178 ArticleCAS Google Scholar
Krieglstein K, Suter-Crazzolara C, Unsicker K . Development of mesencephalic dopaminergic neurons and the transforming growth factor-beta superfamily J Neural Transmis Suppl 1995 46: 209–216 CAS Google Scholar
Lin L-FH et al. A glial cell-line derived neurotrophic factor for midbrain dopaminergic neurons Science 1993 260: 1130–1132 ArticleCASPubMed Google Scholar
Beck KD et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain Nature 1995 373: 339–341 ArticleCASPubMed Google Scholar
Hoffer BJ et al. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivoNeurosci Lett 1994 182: 107–111 ArticleCASPubMed Google Scholar
Kearns C, Gash D . GDNF protects nigral dopaminergic neurons against 6-hydroxydopamine in vivoBrain Res 1995 672: 104–111 ArticleCASPubMed Google Scholar
Tomac A et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivoNature 1995 373: 335–339 ArticleCASPubMed Google Scholar
Sauer H, Rosenblad C, Bjorklund A . Glial cell line-derived neurotrophic factor but not transforming growth factor beta-3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion Proc Nat Acad Sci USA 1995 92: 8935–8939 ArticleCASPubMedPubMed Central Google Scholar
Bowenkamp KE et al. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons J Comp Neurol 1995 355: 479–489 ArticleCASPubMed Google Scholar
Lapchak PA, Miller PJ, Collins F, Jiao S . Glial cell line-derived neurotrophic factor attenuates behavioral deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery Neuroscience 1997 78: 61–72 ArticleCASPubMed Google Scholar
Rosenblad C, Martinez-Serrano A, Bjorklund A . Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson’s disease Neuroscience 1998 82: 129–137 ArticleCASPubMed Google Scholar
Lindner MD et al. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine deletions and Parkinsonian symptoms Exp Neurol 1995 132: 62–76 ArticleCASPubMed Google Scholar
Gash DM et al. Functional recovery in Parkinsonian monkeys treated with GDNF Nature 1996 380: 252–255 ArticleCASPubMed Google Scholar
Ghodsi A et al. Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain Hum Gene Ther 1998 9: 2331–2340 ArticleCASPubMed Google Scholar
Akli S et al. Transfer of a foreign gene into the brain using adenovirus vectors Nat Genet 1993 3: 224–228 ArticleCASPubMed Google Scholar
Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A . Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors Nat Genet 1993 3: 229–234 ArticleCASPubMed Google Scholar
Davidson BL et al. A model system for in vivo gene transfer into the central nervous system using an adenovirus vector Nat Genet 1993 3: 219–223 ArticleCASPubMed Google Scholar
Le Gal La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain Science 1993 259: 988–990 ArticleCASPubMed Google Scholar
Choi-Lundberg DL et al. Dopaminergic neurons protected from degeneration by GDNF gene therapy Science 1997 275: 338–341 Article Google Scholar
Davidson BL, Bohn MC . Recombinant adenovirus: a gene transfer vector for study and treatment of CNS disease Exp Neurol 1997 144: 125–130 ArticleCASPubMed Google Scholar
Horellou P, Sabate O, Buc-Caron M-H, Mallet J . Adenovirus-mediated gene transfer to the central nervous system for Parkinson’s disease Exp Neurol 1997 144: 131–138 ArticleCASPubMed Google Scholar
Choi-Lundberg DL et al. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor Exp Neurol 1998 154: 261–275 ArticleCASPubMed Google Scholar
Bilang-Bleuel A et al. Intrastriatal injection of an adenoviral vector expressing glial cell-line derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson’s disease Proc Natl Acad Sci USA 1997 94: 8818–8823 ArticleCASPubMedPubMed Central Google Scholar
Mandel R, Spratt S, Snyder R, Leff S . Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in rats Proc Natl Acad Sci 1997 94: 14083–14088 ArticleCASPubMedPubMed Central Google Scholar
Bowenkamp K, Lapchak P, Hoffer B, Bickford P . Glial cell line-derived neurotrophic factor reverses motor impairment in 16–17 month old rats Neurosci Lett 1996 211: 81–84 ArticleCASPubMed Google Scholar
Hebert MA, Gerhardt GA . Behavioural and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats J Pharmacol Exp Ther 1997 282: 760–768 CASPubMed Google Scholar
Lapchak P, Miller P, Jiao S . Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer-344 rats Neuroscience 1997 77: 745–752 ArticleCASPubMed Google Scholar
Emerich DF et al. Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts Brain Res 1996 736: 99–110 ArticleCASPubMed Google Scholar
Date I et al. GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice NeuroReport 1998 9: 2365–2369 ArticleCASPubMed Google Scholar
Zigmond M et al. Compensatory responses to partial loss of dopaminergic neurons: studies with 6-hydroxydopamine. In: Schneider J, Gupta M (eds) Current Concepts in Parkinson’s Disease Research Hogrefe and Huber: Göttingen 1993 pp 99–140 Google Scholar
Demarest KT, Riegle GD, Moore KE . Characteristics of dopaminergic neurons in the aged male rat Neuroendocrinology 1980 31: 222–227 ArticleCASPubMed Google Scholar
Unnerstall JR, Long MM . Differential effects of the intraventricular administration of 6-hydroxydopamine on the induction of type II beta-tubulin and tyrosine hydroxylase mRNA in the locus coeruleus of the aging Fischer 344 rat J Comp Neurol 1996 364: 363–381 ArticleCASPubMed Google Scholar
Schallert T . Aging-dependent emergence of sensorimotor dysfunction in rats recovered from dopamine sustained early in life. In: Joseph JA (ed) Central Determinants of Age-Related Decline in Motor Function Annals of New York Academy of Science: New York 1988 pp 108–119 Google Scholar
Bjorklund A, Rosenblad C, Winkler C, Kirik D . Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson’s disease Neurobiol Dis 1997 4: 186–200 ArticleCASPubMed Google Scholar
Ungerstedt U . Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior Acta Physiol Scand 1971 82: 49–68 Article Google Scholar
Sauer H, Oertel WH . Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 1994 59: 401–415 ArticleCASPubMed Google Scholar
Liu FC, Graybiel AM, Dunnett SB, Braughman RW . Intrastriatal grafts derived from fetal striatal primordia. II. Reconstitution of cholinergic and dopaminergic systems J Comp Neurol 1990 295: 1–14 ArticleCASPubMed Google Scholar
Morgan JI, Curran T . Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun Ann Rev Neurosci 1991 14: 421–451 ArticleCASPubMed Google Scholar
Cenci M et al. Dopaminergic transplants normalize amphetamine and apomorphine-induced Fos expression in the 6-hydroxydopamine lesioned striatum Neuroscience 1992 46: 943–957 ArticleCASPubMed Google Scholar
Labandeira-Garcia J et al. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behavior and striatal Fos expression Exp Brain Res 1996 108: 69–84 ArticleCASPubMed Google Scholar
Robertson HA, Peterson MR, Murphy K, Robertson GS . D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior Brain Res 1989 503: 346–349 ArticleCASPubMed Google Scholar
Graybiel AM, Moratalla R, Robertson HA . Amphetamine and cocaine induces drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum Proc Natl Acad Sci USA 1990 87: 6912–6916 ArticleCASPubMedPubMed Central Google Scholar
Robertson GS, Vincenty SR, Fibiger HC . D1 and D2 dopamine receptors differentially regulate c-fos exprssion in striatonigral and striatopallidal neurons Neuroscience 1992 49: 285–296 ArticleCASPubMed Google Scholar
Paul ML, Graybiel AM, David JC, Robertson HA . D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson’s disease J Neurosci 1992 12: 3729–3742 ArticleCASPubMedPubMed Central Google Scholar
Konradi C, Cole RL, Heckers S, Hyman SE . Amphetamine regulates gene expression in rat striatum via transcription factor CREB J Neurosci 1994 14: 5623–5634 ArticleCASPubMedPubMed Central Google Scholar
Berretta S, Robertson HA, Graybiel AM . Dopamine and glutamine agonists stimulate neuron-specific expression of Fos-like protein in the striatum J Neurophysiol 1992 68: 767–777 ArticleCASPubMed Google Scholar
Matheson CR et al. Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor for sensory neurons: comparison with the effects of the neurotrophins J Neurobiol 1997 32: 22–32 ArticleCASPubMed Google Scholar
Byrnes AP, Rusby JE, Wood MJA, Charlton HM . Adenovirus gene transfer causes inflammation in the brain Neuroscience 1995 66: 1015–1024 ArticleCASPubMed Google Scholar
Bohn MC et al. Adenoviral-mediated transgene expression in non-human primate brain Hum Gene Ther 1999 10: 1175–1184 ArticleCASPubMed Google Scholar
Lawrence MS et al. Inflammatory responses and their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus Gene Therapy 1999 6: 1368–1379 ArticleCASPubMed Google Scholar
Martin D et al. Intranigral or intrastriatal injections of GDNF – effects on monoamine levels and behavior in rats Euro J Pharmacol 1996 317: 247–256 ArticleCAS Google Scholar
Lapchak P et al. Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson’s disease Exp Neurol 1997 145: 309–321 ArticleCASPubMed Google Scholar
Morgan D, Finch C . Dopaminergic changes in the basal ganglia: a generalized phenomenon of aging in mammals Ann NY Acad Sci 1998 515: 145–160 Article Google Scholar
Felten D et al. Age-related decline in the dopaminergic nigrostriatal system: the oxidative hypothesis and protective strategies Ann Neurol 1992 32: S133–S136 ArticlePubMed Google Scholar
Roth GS, Joseph JA . Cellular and molecular mechanisms of impaired dopaminergic function during aging Ann NY Acad Sci 1994 719: 129–135 ArticleCASPubMed Google Scholar
Yu T et al. Expression of GDNF family receptor components during development: implications in the mechanisms of interaction J Neurosci 1998 18: 4684–4696 ArticleCASPubMedPubMed Central Google Scholar
Trupp M, Belluardo N, Funakoshi H, Ibanez CF . Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS J Neurosci 1997 17: 3554–3567 ArticleCASPubMedPubMed Central Google Scholar
Glazner GW, Mu X, Springer JE . Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system J Comp Neurol 1998 391: 42–49 ArticleCASPubMed Google Scholar
Kirik D, Rosenblad C, Bjorklund A . Characterization of behavioral and neurodegeneration changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Exp Neurol 1998 153: 259–277 Article Google Scholar
Shults CW, Kimber T, Martin D . Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine NeuroReport 1996 7: 627–631 ArticleCASPubMed Google Scholar
Schwarting R, Huston J . The unilateral 6-hydroxydopamine lesion model in behavioral brain research analysis of functional deficits, recovery and treatments Prog Neurobiol 1996 50: 275–331 ArticleCASPubMed Google Scholar
Brass CA, Glick SD . Sex difference in drug-induced rotation in two strains of rats Brain Res 1981 223: 229–234 ArticleCASPubMed Google Scholar
Tillerson JL, Castro SL, Zigmond MJ, Schallert T . Motor rehabilitation of forelimb use in unilateral 6-hydroxydopamine (6-OHDA) rat model of Parkinson’s disease Soc Neurosci Abstr 1998 24: 1720 Google Scholar
Naldini L et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector Proc Natl Acad Sci USA 1996 93: 11382–11388 ArticleCASPubMedPubMed Central Google Scholar
Kafri T et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors Nat Genet 1997 17: 314–317 ArticleCASPubMed Google Scholar
Kaplitt MG et al. Long-term expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain Nat Genet 1994 8: 148–154 ArticleCASPubMed Google Scholar
McCown TJ et al. Differential and persistent expression pattern of CNS gene transfer by an adeno-associated virus (AAV) vector Brain Res 1996 713: 99–107 ArticleCASPubMed Google Scholar
Lo WD et al. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression Hum Gene Ther 1999 10: 201–213 ArticleCASPubMed Google Scholar
Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis Nat Genet 1994 7: 362–369 ArticleCASPubMed Google Scholar
Fang B et al. Lack of persistence of E1-recombinant adenoviral vectors containing a temperature-sensitive E2a mutation in immunocompetent mice and hemophilia B dogs Gene Therapy 1996 3: 217–222 CASPubMed Google Scholar
Amalfitano A, Chamberlain JS . Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy Gene Therapy 1997 4: 258–263 ArticleCASPubMed Google Scholar
Amalfitano A, Begy CR, Chamberlain JS . Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors Proc Natl Acad Sci USA 1996 93: 3352–3356 ArticleCASPubMedPubMed Central Google Scholar
Amalfitano A et al. Production and characterization of improved adenovirus vectors with E1, E2b and E3 genes deleted J Virol 1998 72: 926–933 ArticleCASPubMedPubMed Central Google Scholar
Crouzet J et al. Recombinational construction in Escherichia coli of infectious adenoviral genomes Proc Natl Acad Sci USA 1997 94: 1414–1419 ArticleCASPubMedPubMed Central Google Scholar
Armentano D et al. Characterization of an adenovirus gene transfer vector containing an E4 deletion Hum Gene Ther 1995 6: 1343–1353 ArticleCASPubMed Google Scholar
Armentano D et al. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors J Virol 1997 71: 2408–2416 ArticleCASPubMedPubMed Central Google Scholar
Parks RJ et al. A helper-dependent adenovirus vector system: removal of helper virus by cre-mediated excision of the viral packaging signal Proc Natl Acad Sci USA 1996 93: 13565–13570 ArticleCASPubMedPubMed Central Google Scholar
Kochanek S et al. A new adenoviral vector: replacement of all viral coding sequences with a 26 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase Proc Natl Acad Sci USA 1996 93: 5731–5736 ArticleCASPubMedPubMed Central Google Scholar
Fisher KJ et al. Recombinant adenovirus deleted of all viral genes for gene therapy therapy of cystic fibrosis Virology 1996 217: 11–22 ArticleCASPubMed Google Scholar
Morsy MA et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene Proc Natl Acad Sci USA 1998 95: 7866–7871 ArticleCASPubMedPubMed Central Google Scholar
Schallert T, Jones TA, Norton DA . A clinically relevant unilateral rat model of Parkinsonian akinesia J Neural Transplant Plast 1992 3: 332–333 ArticlePubMed Central Google Scholar
Schallert T, Lindner MD . Rescuing neurons from trans-synaptic degeneration after brain damage: helpful, harmful, or neutral in recovery of function? Can J Psychol 1990 44: 276–292 ArticleCASPubMed Google Scholar
Jones TA, Schallert T . Overgrowth and pruning of dendrites in adult rats recovering from neocortical damage Brain Res 1992 581: 156–160 ArticleCASPubMed Google Scholar
Kozlowski DA, James DC, Schallert T . Use-dependent exaggeration of neuronal injury after unilateral sensorimotor cortex lesions J Neurosci 1996 16: 4776–4786 ArticleCASPubMedPubMed Central Google Scholar
Coggeshall RE, Lekan HA . Methods for determining numbers of cells and synapses: a case for more uniform standards of review J Comp Neurol 1996 364: 6–15 ArticleCASPubMed Google Scholar
Abercrombie M . Estimation of nuclear population from microtome sections Anat Rec 1946 94: 239–247 ArticleCASPubMed Google Scholar